Sausville EA - Search Results

1

A potential role for imaging technology in anticancer efficacy evaluations.

Hollingshead MG, Bonomi CA, Borgel SD, Carter JP, Shoemaker R, Melillo G, Sausville EA. Hollingshead MG, et al. Among authors: sausville ea. Eur J Cancer. 2004 Apr;40(6):890-8. doi: 10.1016/j.ejca.2003.12.018. Eur J Cancer. 2004. PMID: 15120044

2

The hollow fibre model in cancer drug screening: the NCI experience.

Decker S, Hollingshead M, Bonomi CA, Carter JP, Sausville EA. Decker S, et al. Among authors: sausville ea. Eur J Cancer. 2004 Apr;40(6):821-6. doi: 10.1016/j.ejca.2003.11.029. Eur J Cancer. 2004. PMID: 15120037

3

SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity: part 2: efficacy evaluations.

Alley MC, Hollingshead MG, Pacula-Cox CM, Waud WR, Hartley JA, Howard PW, Gregson SJ, Thurston DE, Sausville EA. Alley MC, et al. Among authors: sausville ea. Cancer Res. 2004 Sep 15;64(18):6700-6. doi: 10.1158/0008-5472.CAN-03-2942. Cancer Res. 2004. PMID: 15374987

4

In vivo models for experimental therapeutics relevant to human cancer.

Gitler MS, Sausville EA, Hollingshead M, Shoemaker R. Gitler MS, et al. Among authors: sausville ea. Cancer Res. 2004 Nov 15;64(22):8478-80. doi: 10.1158/0008-5472.CAN-04-2057. Cancer Res. 2004. PMID: 15548722 No abstract available.

5

In vivo antitumor efficacy of 17-DMAG (17-dimethylaminoethylamino-17-demethoxygeldanamycin hydrochloride), a water-soluble geldanamycin derivative.

Hollingshead M, Alley M, Burger AM, Borgel S, Pacula-Cox C, Fiebig HH, Sausville EA. Hollingshead M, et al. Among authors: sausville ea. Cancer Chemother Pharmacol. 2005 Aug;56(2):115-25. doi: 10.1007/s00280-004-0939-2. Epub 2005 Mar 25. Cancer Chemother Pharmacol. 2005. PMID: 15791458

6

Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway.

Rapisarda A, Uranchimeg B, Scudiero DA, Selby M, Sausville EA, Shoemaker RH, Melillo G. Rapisarda A, et al. Among authors: sausville ea. Cancer Res. 2002 Aug 1;62(15):4316-24. Cancer Res. 2002. PMID: 12154035

7

"Vasocrine" formation of tumor cell-lined vascular spaces: implications for rational design of antiangiogenic therapies.

Rybak SM, Sanovich E, Hollingshead MG, Borgel SD, Newton DL, Melillo G, Kong D, Kaur G, Sausville EA. Rybak SM, et al. Among authors: sausville ea. Cancer Res. 2003 Jun 1;63(11):2812-9. Cancer Res. 2003. PMID: 12782586

8

Role of the National Cancer Institute in acquired immunodeficiency syndrome-related drug discovery.

Sausville EA, Shoemaker RH. Sausville EA, et al. J Natl Cancer Inst Monogr. 2001;(28):55-7. doi: 10.1093/oxfordjournals.jncimonographs.a024259. J Natl Cancer Inst Monogr. 2001. PMID: 11158208 Review. No abstract available.

9

Application of high-throughput, molecular-targeted screening to anticancer drug discovery.

Shoemaker RH, Scudiero DA, Melillo G, Currens MJ, Monks AP, Rabow AA, Covell DG, Sausville EA. Shoemaker RH, et al. Among authors: sausville ea. Curr Top Med Chem. 2002 Mar;2(3):229-46. doi: 10.2174/1568026023394317. Curr Top Med Chem. 2002. PMID: 11944818 Review.

10

Linking the growth inhibition response from the National Cancer Institute's anticancer screen to gene expression levels and other molecular target data.

Wallqvist A, Rabow AA, Shoemaker RH, Sausville EA, Covell DG. Wallqvist A, et al. Among authors: sausville ea. Bioinformatics. 2003 Nov 22;19(17):2212-24. doi: 10.1093/bioinformatics/btg302. Bioinformatics. 2003. PMID: 14630650

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

353 results

Search Page

Filters